Bert Spilker

52 papers receiving 2.6k citations

Hit Papers

Quality of life and pharmacoeconomics in clinical trials1996202620062016199650010001.5k

Peers

Bert Spilker
Comparison fields: 5 of 163
  • Economics and Econometrics 664
  • General Health Professions 481
  • Psychiatry and Mental health 326
  • Pediatrics, Perinatology and Child Health 325
  • Public Health, Environmental and Occupational Health 290
Replace Ivan Barofsky with:
Ivan Barofsky United States
A Fry-Smith United Kingdom
Marjorie A. Bowman United States
Paola Mosconi Italy
William E. Pollard United States
Jackie Brown United Kingdom
John E. Ware United States
R.P. Riemsma United Kingdom
Jones United Kingdom
Jeanne Jackson United States
Bert Spilker relative to Ivan Barofsky United States Ivan Barofsky's profile →
Citations per field
00.5×1.5×1.9×
Ivan Barofsky · 1×
Citations per year

Countries citing papers authored by Bert Spilker

Since Specialization
Citations

This map shows the geographic impact of Bert Spilker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Spilker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Spilker more than expected).

Fields of papers citing papers by Bert Spilker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert Spilker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Spilker. The network helps show where Bert Spilker may publish in the future.

Co-authorship network of co-authors of Bert Spilker

This figure shows the co-authorship network connecting the top 25 collaborators of Bert Spilker. A scholar is included among the top collaborators of Bert Spilker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert Spilker. Bert Spilker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 2
3 0
4 1
5
Quality of life and pharmacoeconomics in clinical trialsbreakdown →
1648
6 1
7
[How to improve the quality of clinical trials and their publications].
3
8 13
9 2
10 2
11
Practical considerations in planning and conducting clinical trials with investigational or marketed drugs.
3
12
The role of bronchoconstrictors in evaluating smooth muscle relaxant activity.
8
13 17
14 7
15 8
16
The action of beta-receptor antagonists on intracellular cardiac potentials.
1
17 6
18 2
19 14
20 31

About Bert Spilker

Bert Spilker is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Statistics, Probability and Uncertainty, having authored 57 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (7 papers), Pharmaceutical Economics and Policy (7 papers) and Ion channel regulation and function (5 papers). The work is most often cited by research in Economics and Econometrics (664 citations), Family Practice (48 citations) and Psychiatry and Mental health (326 citations). Bert Spilker has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Enoch Callaway, Joyce A. Cramer, Anthony C. Segreti, K. M. Dhasmana, Roger A. Burges, Kenneth J. Blackburn, Bita V. Naini, Alan L. Buchman, Peter Cervoni and Joe Kamiya. Their work appears in journals such as JAMA, Journal of Pharmacology and Experimental Therapeutics and Trends in Pharmacological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026